Hypertension written by ChatGPT (Dr. Nehad Jaser Ahmed)
🔹 Introduction
-
Hypertension = persistent elevation of blood pressure (BP).
-
Major modifiable risk factor for cardiovascular (CV) morbidity and mortality.
-
Often called the “silent killer” because it is usually asymptomatic.
🔹 Epidemiology
-
2017 ACC/AHA guideline lowered the threshold for hypertension to ≥130/80 mmHg.
-
Prevalence: ~46% of U.S. adults; higher in non-Hispanic Blacks.
-
Lifetime risk >90% by age 55 for normotensive individuals.
-
More common in men before age 65; in women after 74.
🔹 Etiology
-
Primary (essential) hypertension
-
Accounts for >90% of cases.
-
Multifactorial: genetics, sodium balance, sympathetic overactivity, RAAS dysregulation.
-
-
Secondary hypertension (~10%)
-
Causes: CKD, renovascular disease, endocrine disorders (Cushing’s, hyperaldosteronism, thyroid disease), obstructive sleep apnea, medications (NSAIDs, corticosteroids, contraceptives, stimulants), alcohol, illicit drugs.
-
🔹 Pathophysiology
-
BP = Cardiac Output × Total Peripheral Resistance.
-
Mechanisms:
-
RAAS activation → vasoconstriction, Na⁺/H₂O retention.
-
Sympathetic nervous system overactivity.
-
Endothelial dysfunction (↓ nitric oxide, ↑ endothelin).
-
Electrolyte imbalance (high sodium, low potassium/calcium).
-
Vascular remodeling & stiffness → ↑ peripheral resistance.
-
🔹 Classification (ACC/AHA 2017)
-
Normal: <120/<80 mmHg
-
Elevated: 120–129/<80 mmHg
-
Stage 1 HTN: 130–139 or 80–89 mmHg
-
Stage 2 HTN: ≥140 or ≥90 mmHg
-
Hypertensive crisis: >180/120 mmHg (emergency if end-organ damage present).
🔹 Clinical Presentation
-
Usually asymptomatic.
-
Detected via routine BP measurement.
-
Complications:
-
Brain: stroke, TIA, dementia
-
Heart: LVH, MI, HF
-
Kidneys: CKD, failure
-
Eyes: retinopathy
-
Vessels: PAD, atherosclerosis
-
🔹 Diagnosis
-
Requires ≥2 elevated BP readings on ≥2 visits.
-
Confirm with out-of-office measurements (home or ambulatory monitoring).
-
Rule out white coat or masked hypertension.
-
Evaluate for secondary causes and CV risk factors.
🔹 Management Goals
-
Target BP <130/80 mmHg for most patients.
-
Aim: reduce CV morbidity & mortality.
-
Individualized approach depending on comorbidities.
🔹 Treatment
1. Lifestyle Modifications
-
Weight loss, DASH diet, ↓ sodium, exercise, limit alcohol, smoking cessation.
-
Can reduce systolic BP by 2–20 mmHg depending on intervention.
2. Pharmacologic Therapy
-
First-line agents:
-
ACE inhibitors (ACEi)
-
ARBs
-
Calcium channel blockers (CCBs)
-
Thiazide diuretics
-
-
β-blockers: not first-line (except if CAD, HF, or other compelling indications).
-
Stage 1 HTN: usually 1 drug.
-
Stage 2 HTN: start 2 drugs.
-
Resistant HTN: ≥3 drugs (including diuretic).
3. Special Considerations
-
Older adults: start low doses to avoid adverse effects.
-
Specific comorbidities guide drug choice:
-
CKD → ACEi/ARB
-
HF → ACEi/ARB + β-blocker
-
Diabetes → ACEi/ARB preferred
-
🔹 Key Concepts
-
Hypertension is chronic, common, and treatable.
-
Early diagnosis is critical.
-
Both lifestyle and pharmacotherapy are essential for control.
-
BP control prevents stroke, MI, kidney disease, and premature death.
تعليقات
إرسال تعليق